ECVT:NYSEEcovyst Inc. Analysis
Data as of 2026-09-15 - not real-time
$10.54
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ecovyst Inc. is priced at $10.54 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 12.5%. Relative strength is 51.7 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $9.70 and resistance around $10.73.
On valuation the read is fair — an earnings multiple of 45.8, absent a reliable peer benchmark. Analyst price targets sit 43.9% above the current price. Revenue is growing at 42.0% on a -7.1% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 38.2%, a beta of 0.68 and a maximum drawdown of 33.7%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
On valuation the read is fair — an earnings multiple of 45.8, absent a reliable peer benchmark. Analyst price targets sit 43.9% above the current price. Revenue is growing at 42.0% on a -7.1% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 38.2%, a beta of 0.68 and a maximum drawdown of 33.7%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
Ecovyst Inc ECVT raises full-year guidance on robust sulfuric acid demand and successful integration of Calabrian...Sales surged 42% as Calabrian acquisition closed and sulfur demand remained strong.WAYNE, Pa., Aug. 5, 2026 /PRNewswire/ -- Ecovyst Inc. NYSE: ECVT "Ecovyst" or the "Company" , a leading provider of...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 11.72
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 11.72
- Analyst targets imply +43.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -7.1%
- Analyst targets imply +43.9% versus the current price
- Revenue growth of +42.0%
Key Metrics & Analysis
Financial Health
Revenue Growth42.00%
Profit Margin-7.06%
P/E Ratio45.8
ROE4.04%
ROA3.67%
Debt/Equity93.10
P/B Ratio2.0
Op. Cash Flow$148.3M
Free Cash Flow$125.9M
Technical Analysis
TrendBearish
RSI51.7
Support$9.70
Resistance$10.73
MA 20$10.21
MA 50$11.12
MA 200$11.72
MACDBullish
VolumeDecreasing
Fear & Greed Index90.71
Valuation
Fair Value$34.36
Target Price$15.17
Upside/Downside43.90%
GradeFair
TypeGrowth
Risk Assessment
Beta0.68
Volatility38.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.